Now showing items 21-22 of 22
Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing
(Public Library of Science, 2012-01-19)
Results: Genome-wide analysis uncovered reproducible gene expression signatures for both adenomas and cancers compared to controls. 386/489 (79%) of the adenoma and 439/529 (83%) of the adenocarcinoma biomarkers were ...
Modeling the cost-effectiveness of strategies for treating esophageal adenocarcinoma and high-grade dysplasia
Objective: To synthesize cost and health outcomes for current treatment pathways for esophageal adenocarcinoma and high grade dysplasia, and model comparative net clinical and economic benefits of alternative management ...